Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
02/2002
02/28/2002WO2001080921A3 Native protein mimetic fibers, fiber networks and fabrics for medical use
02/28/2002WO2001068654A3 Tubulin binding ligands and corresponding prodrug constructs
02/28/2002US20020026065 2-hydroxy-3 - (4-hydroxy-3-sulfonamidophenyl) - propylamines useful as beta 3 adrenergic agonists
02/28/2002US20020026049 Organometallic monoacylalkylphosphines
02/28/2002US20020026027 Polyamide oligomers
02/28/2002US20020026021 Ionic perfluorovinyl compounds and their uses as components of ionic conductors of the polymer type, of selective membranes or of catalysts
02/28/2002US20020025976 Thiazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use
02/28/2002US20020023573 Materials comprising organic phosphorous-containing groups bonded to a mineral oxide via oxygen atoms
02/28/2002DE10040726A1 Cycloaliphatisch-aromatische Diphosphine und ihre Verwendung in der Katalyse Cycloaliphatic-aromatic diphosphines and their use in catalysis
02/28/2002CA2420179A1 Composition and method for inhibiting platelet aggregation
02/27/2002EP1182467A1 Optical material
02/27/2002EP1182205A1 Chiral diphosphines via 2,3 -sigmatropic rearrangement.Application in asymmetric transition metal catalysis
02/27/2002EP1182195A1 Cyclic compounds and uses thereof
02/27/2002EP1181283A1 Diaminothiazoles and their use for inhibiting protein kinases
02/27/2002EP1181271A2 Naphthalene ureas as glucose uptake enhancers
02/27/2002EP1091804B1 Catalyst comprising a complex of a metal from subgroup viii based on a bidentate phosphonite ligand, and method for producing nitriles
02/27/2002EP0927178B1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
02/27/2002EP0892789B1 Irreversible inhibitors of tyrosine kinases
02/27/2002EP0643626B1 Method of producing epoxychromans with a chiral catalyst
02/27/2002CN1337962A Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors
02/27/2002CN1337947A Acetylenic sulfonamide thiol TACE inhibitors
02/27/2002CN1337400A Organic arsine compounds with the function of inducing cancer cell to die and their synthesis process
02/27/2002CN1337399A Prepn process of vitamine C-magnesium phosphorate for cosmetics
02/27/2002CN1337398A Fluoroalkyl phosphate for electrochemical cells
02/27/2002CN1079798C 3-aryl-tetronic acid derivatives, the production thereof and the use thereof as antiparasitic agents, and the intermediate
02/26/2002US6350925 Haloethylation of aromatic compounds
02/26/2002US6350916 Selective oxidation of alcohols to aldehydes or ketones
02/26/2002US6350910 Stereospecific isomerisation of allylamines with the aid of immobilized phosphorated chiral ligands
02/26/2002US6350905 Catalytic reaction of olefin in the presence of osmium catalyst for aminohydroxylation
02/26/2002US6350903 Coordination compounds are useful as catalysts for the polymerization or olefins with carbon monoxide and for the polymerization of acrylic monomers
02/26/2002US6350892 Trifluoromethyl ketone analogs as selective cPLA2 inhibitors
02/26/2002US6350819 Separation of the desired product from the catalyst is facilitated; hydroformylation catalyst; branches contain terminal groups derived from organophosphites, organophosphonites and/or organophosphinites.
02/26/2002US6350763 Small molecules useful in the treatment of inflammation disease
02/26/2002US6350747 Protein serine/threonine kinase and protein tyrosine kinase enzyme inhibitors; angiogenesis inhibitors; antitumor and antiproliferative agents
02/26/2002US6350419 Supported liquid membrane/ strip dispersion for removal of metals
02/26/2002CA2230237C Process for preparing quinazolin-4-one derivative
02/26/2002CA2057048C Vitamin d analogues
02/21/2002WO2002014558A2 New hydrazide building blocks and hydrazide modified biomolecules
02/21/2002WO2002014344A2 Amino acid-derived cyclic phosphonamides and methods of synthesizing the same
02/21/2002WO2002014335A1 Process for the preparation of hindered phosphites
02/21/2002WO2002014334A1 Phenol compounds, resin compositions and products of curing thereof
02/21/2002WO2002014332A1 Preparation of n-protected-3-pyrrolidine-lactam substituted phosphonium salts
02/21/2002WO2002014331A1 Amino acid-derived phosphonamidic anhydrides and methods of preparing the same
02/21/2002WO2002014330A1 Cycloaliphatic/aromatic diphosphines and use thereof in catalysis
02/21/2002WO2002014329A1 Compositions with vascular damaging activity
02/21/2002WO2002014281A1 Pyridine derivatives as inhibitors of p38
02/21/2002WO2002013964A2 Suitable catalyst for producing nitriles
02/21/2002WO2001060820A3 Matrix metalloproteinase inhibitors and uses thereof
02/21/2002US20020022741 Metathesis syntheses of pheromones or their components
02/21/2002US20020022733 Synthesis of ruthenium of osmium metathesis catalysts
02/21/2002US20020022636 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
02/21/2002US20020022607 Synthetic acyclic, aromatic or heteroaromatic acyl phosphates and beta -lactamase inhibitors; also useful for overcoming bacterial antibiotic resistance
02/21/2002US20020022590 Useful as antibiotics; reduced tissue accumulation and/or nephrotoxicity when administered to a mammal; useful against vancomycin-resistant microorganisms
02/21/2002US20020022182 Fluoroalkyl phosphates for use in electrochemical cells
02/21/2002US20020020025 Crosslinking agents for textile finishing baths and process for using same
02/21/2002DE10039389A1 Carbenoide enthaltende Rutheniumkomplexe Carbenoids containing ruthenium
02/21/2002DE10039265A1 New 2-acylamino-5-aminosulfonyl-1,3-thiazole derivatives, useful as antiviral agents, especially for treatment or prophylaxis of herpes simplex virus infections
02/21/2002DE10035189A1 Arzneimittel zur oralen Applikation mit einem Gehalt an 3-N-Formylhydroxylaminopropylphosphonsäureestern oder 3-N-Acetylhydroxylaminopropylphosphonsäureestern als Wirkstoff Pharmaceuticals for oral application with a content of 3-N-Formylhydroxylaminopropylphosphonsäureestern or 3-N-Acetylhydroxylaminopropylphosphonsäureestern as an active ingredient
02/21/2002CA2419775A1 Amino acid-derived cyclic phosphonamides and methods of synthesizing the same
02/21/2002CA2418389A1 Pyridine derivatives as inhibitors of p38
02/20/2002EP1180396A1 Materials comprising phosphorus organic groups linked to an inorganic oxide by oxygen atoms
02/20/2002EP1180099A1 New compounds
02/20/2002EP0842168B1 Process for the preparation of 1,2-dioxetane compounds and novel sulfur-substituted 1,2-dioxetane compounds as intermediates
02/20/2002CN1336931A Process for producing deoiled phosphatides
02/20/2002CN1336923A Recovery of benzodihydropyran derivatives
02/20/2002CN1336376A Prepn. method for high-purity bisalkyl phosphate
02/20/2002CN1079397C 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists
02/19/2002USRE37556 Superoxide radical inhibitor
02/19/2002US6348621 Process for the carbonylation of ethylene and catalyst system for use therein
02/19/2002US6348612 Chiral amido-phosphine-phosphinite compounds
02/19/2002US6348588 Method of cleaving a nucleic acid bulge
02/19/2002US6348587 Purine or pyrimidine base derivatives; anticancer, antitumor and antiproliferative agents; treating hiv and hepatitis
02/19/2002CA2198453C Metalorganic compounds
02/14/2002WO2002012253A1 Use of chiral diphosphines as optically active ligands
02/14/2002WO2002012243A2 SYNTHESIS OF (R)-3-(4-BROMOBENZYL)-1-(3,5-DICHLOROPHENYL)-5-IODO-3-METHYL-1-H-IMIDAZO[1,2-a]IMIDAZOL-2-ONE
02/14/2002WO2002012230A1 Intermediate of carbapenem antibiotics and process for the preparation thereof
02/14/2002WO2002012165A1 (poly)ethereal ammonium salts of herbicides bearing acidic moieties and their use as herbicides
02/14/2002WO2002012149A2 Method for preparing alkoxyamines from nitroxides
02/14/2002WO2002011743A2 Treatment of prostate cancer
02/14/2002WO2002011737A2 Anti-inflammatory medicament
02/14/2002WO2002011666A2 Derivatives of branched-chain lipophilic molecules and uses thereof
02/14/2002WO2002006279A8 Efficient method of synthesizing combretastatin a-4 prodrugs
02/14/2002WO2001044324A3 Polymerization of olefins
02/14/2002WO2001036973A3 Method for solubilising optical markers
02/14/2002WO2000052014A3 Method for producing n-phosphonomethyl iminodiacetic acid
02/14/2002WO1995029669A3 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
02/14/2002US20020019565 Process for making iminodiacetic acid compounds from monoethanolamine substrates
02/14/2002US20020019564 Process and catalyst for dehydrogenating primary alcohols to make carboxylic acid salts
02/14/2002US20020019553 Chemiluminescence
02/14/2002US20020019551 Synthesis of functionalized lithium initiator
02/14/2002US20020019521 Separation of olefinic isomers
02/14/2002US20020019430 Nervous system and psychological disorders
02/14/2002US20020019381 In fewer steps and is obtained in higher yield; chemical intermediates; useful in treating methicillin resistent Staphylococcus aureus and Pseudomonas aeruginosa
02/14/2002US20020017629 Mixture containing acid and alcohol
02/14/2002DE10038858A1 Fluoralkylphosphate zur Anwendung in elektrochemischen Zellen Fluoroalkyl phosphates for use in electrochemical cells
02/14/2002CA2417836A1 Use of chiral diphosphines as optically active ligands
02/14/2002CA2416906A1 Synthesis of (r)-3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-h-imidazo[1,2-a]imidazol-2-one
02/13/2002EP1178995A1 Manufacture of olefin/carbon monoxide polymers
02/13/2002EP1178994A1 Improved process for phosphorylation and compounds produced by this process
02/13/2002EP1178955A1 Polyalcoxyamines obtained from beta-substituted nitroxides